《大行报告》花旗上调创科(00669.HK)目标价至153元 评级「买入」
花旗发表研究报告指,创科(00669.HK)的直接竞争对手SWK预测2021年每股盈利将增长增长11%,高於预期的9%,指出在疫情爆发後创科及SWK均迅速巩固市场地位,去年销售增长大大高於行业增长,因此将创科2021至2022年的盈利预测上调1%至3%。
该行预期,去年下半年盈利将按年增长20%,增幅高於上半年的16%,其中占总收入贡献一半的专业工具业务,在利润率增长的推动下,下半年收入增长料加快至27%;家居DIY及户外园艺工具品牌RYOBI的增长则受居家需求疲软影响,预期由上半年的15%,温和回落至10%。
花旗指,创科的股价日前受拜登刺激政策延期所拖累而下跌,为投资者提供入市机会,将目标价由128元上调至153元,为2022年预测市盈率的约33倍,予「买入」评级。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.